Skip to main content
CLXClorox Company (The)Sell4.7·$83.80
SellHigh Confidence
Investment thesis

Clorox has a credible earnings beat track record and solid peer-relative standing, but the stock has run into a natural ceiling with less than 3% of room remaining to the consensus target, free cash flow conversion is critically weak at 8% of net income, and a confirmed downtrend with a death cross in place argues for patience rather than new exposure.

Thesis pillars

  • Free Cash Flow Quality Concern→Stable
  • Confirmed Downtrend Blocks Entry↑Improving
  • Limited Upside To Consensus Ceiling→Stable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Clorox Company (The) (CLX) Stock Analysis

Falling Knife setup

SellVALUE-TRAP 1/5ShortHigh Confidence

Consumer Defensive · Household & Personal Products

Sell if holding. At $83.80, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 8.2%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8).

The Clorox Company markets branded consumer products across cleaning, household, health, and lifestyle categories — Clorox bleach, Glad bags, Pine-Sol, Kingsford charcoal, Burt's Bees — sold through retailers and e-commerce. Its largest customer, Walmart and its affiliates,... Read more

$83.80+8.2% A.UpsideScore 4.7/10#17 of 18 Household & Personal Products
QualityF-score4 / 9FCF yield1.09%
IncomeYield6.11%(5y avg 3.54%)Payout103.12%at-risk
Stop $79.15Target $90.69(analyst − 10%)A.R:R 1.3:1
Analyst target$100.76+20.2%17 analysts
$90.69our TP
$83.80price
$100.76mean
$154

Sell if holding. At $83.80, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 8.2%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8). Chart setup: Death cross, below all MAs, RSI 31, MACD bearish. Score 4.7/10, high confidence.

Passes 5/9 gates (clean insider activity, news events none recent, earnings proximity 38d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: moderate.

10-K grounded · weekly refresh

About Clorox Company (The)

About Clorox Company (The)

Clorox's largest customer, Walmart Stores, Inc. and its affiliates, accounted for 27% of consolidated net sales in fiscal 2025, up from 25% in fiscal 2024 and 26% in fiscal 2023, with Walmart purchases spanning all of the company's reportable segments. The company's five largest customers together accounted for nearly half of consolidated net sales in each of fiscal 2025, 2024, and 2023, while no other single customer reached the 10% disclosure threshold.

Clorox earns revenue selling nationally advertised branded consumer products that compete directly against private-label alternatives across grocery, club, drug, dollar-store, mass-merchandise, and e-commerce channels, with grilling-product sales concentrated in the March-through-September season due to weather-driven demand. The company's patent and trademark portfolio underpins its brand-equity strategy, and it vigorously enforces those rights against infringement as a competitive defense against lower-cost private-label entrants. Because Walmart alone represents roughly a quarter of consolidated net sales and the top five retail customers together approach half, Clorox's trade-promotion spending, shelf-space negotiations, and inventory terms with a small number of large retail buyers carry outsized weight in the company's results relative to a more fragmented customer base. The company's IGNITE strategy ties its purpose and sustainability goals to corporate governance, framing brand reputation and product performance as its primary basis for competing on price and image against both branded and private-label rivals.

Show full overview

Clorox's clearest concentration risk is retailer-side rather than commodity or geography: Walmart and its affiliates alone represent more than a quarter of consolidated net sales, occurring across every one of Clorox's reportable segments rather than being isolated to one product category, and the top five customers combined approach half of net sales. That breadth of exposure across segments means a pricing dispute, inventory pullback, or shelf-space reallocation at Walmart specifically would ripple through Clorox's entire portfolio simultaneously, rather than being contained to a single brand or category the way a narrower private-label threat might be.

See also: Consumer Defensive · Household & Personal Products

From Clorox Company (The)'s most recent 10-K filing, extracted August 30, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-09-26
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Nov 3, 202638d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Consumer Defensive): +0.8
Strong earnings beat streak (3/4)
Risks
Thin upside margin: 8.2%
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8)
Leverage penalty (D/E 22.2): -1.5

Key Metrics

P/E (TTM)17.9
P/E (Fwd)13.4
Mkt Cap$10.1B
EV/EBITDA13.8
Profit Mgn8.7%
ROE163.8%
Rev Growth-2.0%
Beta0.54
Dividend6.11%
Rating analysts27

Quality Signals

Piotroski F4/9

Options Flow

P/C0.13bullish
IV41%normal

Concentration Risks(10-K Item 1A)

  • MEDIUMCustomerWalmart Stores, Inc.27%
    10-K Item 1: 'Net sales to the Company’s largest customer, Walmart Stores, Inc. and its affiliates, were 27%, 25% and 26% of consolidated net sales for each of the fiscal years ended June 30, 2025, 2024 and 2023, respectively, and occurred across all of the Company’s reportable segments.'
  • MEDIUMCustomerfive largest customers
    10-K Item 1: 'The Company’s five largest customers accounted for nearly half of the Company’s consolidated net sales for each of the fiscal years 2025, 2024 and 2023.'

Material Events(8-K, last 90d)

  • 2026-05-28Item 5.02HIGH
    Clorox Chair and CEO Linda Rendle asked the Board on May 26, 2026 to initiate a CEO search, stepping down for health reasons. She remains Chair and CEO during the search and will serve in an advisory role after a successor is appointed. No successor named yet.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Revenue shrinking — -2.0% YoY. Growth thesis broken unless recovery story develops.static

Earnings Growth
0.0
Revenue Growth
2.0
Declining revenue: -2%

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Ma Position
1.0
Volume
1.5
Rsi
3.5
Obv
10.0
Volume accumulation (rising OBV)Below 200-MA, MA slope -1.2%/30d — confirmed downtrend
GatesMomentum 3.2<4.5A.R:R 1.3 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentInsider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 38d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Moderate
RSI
31 · Neutral
↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $81.60Resistance $104.85

Price Targets

$79
$91
A.Upside+8.2%
A.R:R1.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! momentum at 3.2 (below the engine's 4.5 threshold)
! asymmetry at 1.3 (below the engine's 1.5 threshold)@spot
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-03 (38d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLX stock a buy right now?

Sell if holding. At $83.80, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 8.2%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8). Chart setup: Death cross, below all MAs, RSI 31, MACD bearish. Prior stop was $79.15. Score 4.7/10, high confidence.

What is the CLX stock price target?

Take-profit target: $90.69 (+8.2% upside). Prior stop was $79.15. Stop-loss: $79.15.

What are the risks of investing in CLX?

Thin upside margin: 8.2%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8); Leverage penalty (D/E 22.2): -1.5.

Is CLX overvalued or undervalued?

Clorox Company (The) trades at a P/E of 17.9 (forward 13.4). TrendMatrix value score: 6.9/10. Verdict: Sell.

What do analysts say about CLX?

27 analysts cover CLX with a consensus score of 2.7/5. Average price target: $101.

What does Clorox Company (The) do?The Clorox Company markets branded consumer products across cleaning, household, health, and lifestyle categories —...

The Clorox Company markets branded consumer products across cleaning, household, health, and lifestyle categories — Clorox bleach, Glad bags, Pine-Sol, Kingsford charcoal, Burt's Bees — sold through retailers and e-commerce. Its largest customer, Walmart and its affiliates, accounted for 27% of consolidated net sales in fiscal 2025, and its five largest customers together made up nearly half of net sales for three straight years.

Related stocks: SPB (Spectrum Brands Holdings, Inc.) · ELF (e.l.f. Beauty, Inc.) · NWL (Newell Brands Inc.) · IPAR (Interparfums, Inc.) · KVUE (Kenvue Inc.)
Home › Stocks › CLX

Latest news

Latest News

Yahoo Finance59d ago
MarketBeat59d ago
TradingKey59d ago
TradingKey59d ago
Yahoo Finance59d agoEarnings
Yahoo Finance59d agoEarnings
TradingView151d agoEarnings
MarketBeat157d agoAnalyst
GuruFocus60d ago
MarketBeat60d ago
Sahm60d agoEarnings
Seeking Alpha151d ago
GuruFocus158d agoAnalyst
MarketBeat158d ago
Seeking Alpha158d ago
TradingView58d agoEarnings
MarketBeat58d ago
MarketBeat58d ago
StockStory149d agoEarnings
MarketWatch149d ago
Loading more...